SYN-TECH Chem. & Pharm. Co., Ltd. (TPEX:1777)
Taiwan
· Delayed Price · Currency is TWD 88.60
-0.40 (-0.45%)
Apr 24, 2025, 1:30 PM CST
SYN-TECH Chem. & Pharm. Revenue
In the year 2024, SYN-TECH Chem. & Pharm. had annual revenue of 1.26B TWD with 12.83% growth. SYN-TECH Chem. & Pharm. had revenue of 314.27M in the quarter ending December 31, 2024, with 15.59% growth.
Revenue
1.26B
Revenue Growth
+12.83%
P/S Ratio
3.14
Revenue / Employee
5.54M
Employees
227
Market Cap
3.95B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 1.26B | 142.98M | 12.83% |
| Dec 31, 2023 | 1.11B | 128.39M | 13.02% |
| Dec 31, 2022 | 986.30M | 93.07M | 10.42% |
| Dec 31, 2021 | 893.23M | -90.56M | -9.20% |
| Dec 31, 2020 | 983.79M | 37.38M | 3.95% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| PharmaEssentia | 9.73B |
| Caliway Biopharmaceuticals | 44.43M |
| Bora Pharmaceuticals Co., LTD. | 19.25B |
| Lotus Pharmaceutical | 18.58B |
| Polaris Group | 107.00M |
| Oneness Biotech | 117.93M |
| Pegavision | 6.82B |
| Lumosa Therapeutics | 39.15M |